Sign in
CompletedNo phase

US Development and Evaluation Study of a Patch-Based PSG System

Key facts

Who runs it
Onera BV
Where
Birmingham and St Louis, United StatesSee the 2 sites
Trial code
Status
Completed
People taking part
70 people enrolled
Started
4 Aug 2023
Ended
2 Sept 2024
Type of study
Interventional
Treatments tested
  • Home PSG Assessment
Record updated
18 March 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • 18 years and older
  • Referral for a suspected sleep disorder requiring a sleep diagnostic study

Who cannot take part

  • History of allergic reactions to adhesives or hydrogels or a family history of adhesive skin allergies
  • Severe skin condition at sites of patch administration such as wounds, burns or on any damaged skin
  • Has an implanted cardiac stimulator or diaphragmatic pacer
  • Will be exposed to high-frequency surgical equipment, near strong magnetic fields or with devices such as MRIs, external cardiac stimulators during their use of the Onera device
  • Inability to provide informed consent
  • Has an anatomical abnormality that, in the opinion of the Principal Investigator, makes the subject ineligible for inclusion

Where in United States

  • The Sleep Disorders Center of AlabamaBirmingham, United States
  • Clayton Sleep InstituteSt Louis, United States

About the trial

What the trial wants to find out

The purpose of this study is continue the development and evaluation of the Onera system as well as the procedures and best practices for dispensing, instruction, use and reportability of results.

The group in the trial

  • Home PSG AssessmentTreatment being tested

    Testing of the Onera STS in the home environment with the current device shipment method and instructions.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
18 March 2025